Our Investment Focus
As a strategic fund, SGBV invests directly in private early-stage biotech and healthcare innovation companies with promising new products or technologies that align with Sanofi’s current and future areas of business interest.
Current core areas of strategic interest include:
- rare diseases,
- immune-mediated diseases,
- cardiovascular disease,
- breakthrough therapies in other core areas of interest,
- integrated health solutions.